79 related articles for article (PubMed ID: 8866768)
1. Integration of family and drug treatment strategies in the treatment of schizophrenia: a selective review.
Schooler NR
Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():73-80. PubMed ID: 8866768
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
Schooler NR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
[TBL] [Abstract][Full Text] [Related]
4. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
6. Dosing issues and depot medication in the maintenance treatment of schizophrenia.
Kane JM
Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():65-71. PubMed ID: 8866767
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
Leucht S; Heres S
J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
[TBL] [Abstract][Full Text] [Related]
8. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
Chue P
J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
10. [Strategies of long-term medication in schizophrenia].
Gaebel W
Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S113-9. PubMed ID: 11533861
[TBL] [Abstract][Full Text] [Related]
11. The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia.
Busch AB; Frank RG; Lehman AF
Arch Gen Psychiatry; 2004 May; 61(5):442-8. PubMed ID: 15123488
[TBL] [Abstract][Full Text] [Related]
12. [Rehabilitation in schizophrenia--guidelines for including psychosocial measures].
Katschnig H
Wien Med Wochenschr; 1998; 148(11-12):273-80. PubMed ID: 9746970
[TBL] [Abstract][Full Text] [Related]
13. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of schizophrenia].
Houy-Durand E; Thibaut F
Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
[TBL] [Abstract][Full Text] [Related]
15. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
16. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
17. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acute psychosis without neuroleptics: two-year outcomes from the Soteria project.
Bola JR; Mosher LR
J Nerv Ment Dis; 2003 Apr; 191(4):219-29. PubMed ID: 12695732
[TBL] [Abstract][Full Text] [Related]
19. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
Misdrahi D; Llorca PM; Lançon C; Bayle FJ
Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
Mishara AL; Goldberg TE
Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
